Quantifying the number, type and distribution of immune cells in oncology tissue is key to obtaining a greater understanding of the actions of immunotherapies as part of immuno-oncology research. With the advent of advanced quantitative digital histopathology...
Quantification of Tumour and Stroma Cell Content within Laser Microdissection (LMD) Tissue
According to the American Cancer Society, an estimated 88,000 new cases of gynecologic cancer are diagnosed per year in the U.S., and over 29,000 American women will lose their battle with this deadly disease. Over the past 12 months, OracleBio has supported work lead...
Selecting the Correct Therapeutic Indication: A Case Study Utilising Tissue Microarrays (TMA) with Digital Image Analysis
Selecting the right therapeutic disease indication in which to trial new therapies is a notoriously difficult task. Failure to choose the right indication can result in failure in Phase II/III trials resulting in drug discovery programs being halted which, given...
6 Ways to Improve the Quality of Quantitative Histopathology Data
The production of robust tissue-based quantitative histopathology data is completely dependent on high quality sample preparation and staining. Failure to ensure that samples are of a high quality can hinder subsequent image analysis processes, negatively impact on...
Quantification of Dual LAG-3 and CD3 IHC-stained T Cells in Clinical Tumor Tissue using Image Analysis
The characterisation of immune cells within the tumor microenvironment and their potential impact on cancer treatment and prognosis has been the subject of intense investigation over recent years. Non-small cell lung cancer (NSCLC) patients have impaired immune...
Quality Counts: Implementing Quality Standards as part of Image Analysis in Clinical R&D
Delivering robust and meaningful data in support of an ever-increasing demand on tissue-based biomarker evaluations is critical to improving decision making in clinical R&D. To realise these requirements, it is vitally important to implement quality standards...
Use of histology image analysis to aid selection of oncology xenograft models for drug development
The development of new oncology therapies is routinely supported through the use of various xenograft models. Identifying the most suitable models for use in pre-clinical oncology programmes is key to establishing a successful translational R&D strategy. The...






